Haemodynamic monitoring specialist, Deltex Medical’s French distributor, Gamida has been awarded a new tender to supply hospitals in Paris with CardioQ-ODM+ equipment. Deltex’s long term partner has won an eight…
Fluid management monitoring technologies can reduce mortality rates for elective procedures, improve the quality of care for more than 800,000 patients a year, and save the NHS at least £400m annually.
Sir David Nicholson, Chief Executive of the NHS in England
Helping to deliver better patient care and recovery through technology…
Sign up to stay in touch
Our e-newsletter is a great way to keep up with the latest news and information about Deltex Medical.
- Clinical Library & Education
- Innovation Health & Wealth Report
Innovation Health and Wealth: Accelerating Adoption and Diffusion in the NHS, was published in December 2011 and identified Oesophageal Doppler Monitoring (ODM) as one of six High Impact Innovations recommended for widespread use across the NHS. The aim; to improve productivity, quality and patient outcomes.